For quite some time now we’re been talking about the hot new migraine-fighting hopefuls – CGRP antibodies. In fact, there’s a race to get these new medications to the market.
One of these drugs, now known as “LY2951742”, is being tested for cluster headache, both chronic and episodic. So if you have cluster, and you’re in the USA, you have a unique chance to get in on the cutting edge of research.
They are looking for adult volunteers, with a history of either episodic or chronic cluster headache. There is more information listed, including who to contact and how, if you click through the links above.
To find out more about CGRP, see:
- More on the recent LY2951742 studies for migraine and cluster
- New Migraine Drugs: What About CGRP?
- The Secret of CGRP
- The “Revolution” in Migraine Treatment (Dr. Peter Goadsby)